发明申请
US20130252257A1 QUANTIFICATION OF CIRCULATING STEM AND PROGENITOR CELLS AS A MEANS OF ASSESSING EFFICACY OF NATUROPATHIC INTERVENTIONS
审中-公开
循环干细胞和祖细胞的定量作为评估自然疗法干预效果的手段
- 专利标题： QUANTIFICATION OF CIRCULATING STEM AND PROGENITOR CELLS AS A MEANS OF ASSESSING EFFICACY OF NATUROPATHIC INTERVENTIONS
- 专利标题（中）： 循环干细胞和祖细胞的定量作为评估自然疗法干预效果的手段
-
申请号： US13621702申请日： 2012-09-17
-
公开(公告)号： US20130252257A1公开(公告)日： 2013-09-26
- 发明人: Amit Patel , Annette M. Marleau
- 申请人： Amit Patel , Annette M. Marleau
- 申请人地址： US AZ Phoenix
- 专利权人： Creative Medical Health, Inc.
- 当前专利权人： Creative Medical Health, Inc.
- 当前专利权人地址： US AZ Phoenix
- 主分类号： G01N33/569
- IPC分类号： G01N33/569
摘要：
Disclosed are tests, correlations and “theranostic” interventions aimed at optimizing general health through quantification of cells with regenerative potential in circulation. Some embodiments include use of circulating endothelial progenitor cell (EPC) testing as a means of quantifying general health status in a patient. The combination of EPC testing together with a naturopathic intervention, wherein the selection and dosage of said naturopathic intervention is tailored based on said quantitative test is provided. In other embodiments, regenerative cells are selected from the group comprising of very small embryonic like cells (VSEL), CD34 cells with hematopoietic potential, and circulating mesenchymal stem cells (MSC). Naturopathic interventions include recommendations of lifestyle modification, dietary supplements, intravenous vitamins, detoxification, acupuncture, and guided imagery.
信息查询
IPC分类:
